Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about NTLA
Recent news which mentions NTLA
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Analyst Ratings for Intellia Therapeutics
June 16, 2022
Tickers
NTLA
Tags
Benzinga
BZI/AAR
NTLA
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 16, 2022
June 16, 2022
Tickers
AIRS
AJG
APLE
AWI
Tags
VTOL
EMN
BA
From
Benzinga
Analyst Ratings for Intellia Therapeutics
May 24, 2022
Tickers
NTLA
Tags
NTLA
Market News
Analyst Ratings
From
Benzinga
Why Editas Medicine's Shares Fell 28.9% This Week
May 13, 2022
Tickers
CRSP
EDIT
NTLA
Tags
EDIT
NTLA
Market News
From
Motley Fool
10 Biggest Price Target Changes For Monday
May 09, 2022
Tickers
CI
EPAM
GH
K
Tags
Health Care Distributors
Small Cap
SPCE
From
Benzinga
The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study
May 05, 2022
Tickers
ABUS
AGIO
ALDX
ARGX
Tags
News
JAZZ
DSKYF
From
Benzinga
Earnings Preview For Intellia Therapeutics
May 04, 2022
Tickers
NTLA
Tags
Benzinga
BZI/EP
NTLA
From
Benzinga
How To Attend Intellia Therapeutics Q1 2022 Earnings Conference Call
May 02, 2022
Tickers
NTLA
Tags
Earnings
Market News
NTLA
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 28, 2022
April 28, 2022
Tickers
ACHR
ALL
AM
ARVN
Tags
AVDX
BZI/Ratings
WAB
From
Benzinga
4 Analysts Have This to Say About Intellia Therapeutics
April 28, 2022
Tickers
NTLA
Tags
Benzinga
BZI/AAR
NTLA
From
Benzinga
Stocks That Hit 52-Week Lows On Thursday
April 21, 2022
Tickers
HLBZ
HNST
HYFM
HYRE
Tags
RPID
QRTEA
RDFN
From
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
April 20, 2022
Tickers
ACLX
ADVM
AFCG
ALLK
Tags
CYCN
FIXX
AFCG
From
Benzinga
3 Top Biotech Stocks Ready for a Bull Run
April 20, 2022
Tickers
BNTX
NTLA
PFE
REGN
Tags
Market News
NTLA
PFE
From
Motley Fool
3 Ominous Reasons to Avoid This Biotech Pioneer
April 19, 2022
Tickers
CRSP
EDIT
NTLA
Tags
Market News
EDIT
NTLA
From
Motley Fool
CRISPR Stocks Are Huge -- Here's Why They'll Get Even Bigger by 2030
April 13, 2022
Tickers
CRSP
EDIT
NTLA
VRTX
Tags
EDIT
NTLA
Market News
From
Motley Fool
Who Benefits From Amazon's Stock Split?
March 16, 2022
Tickers
AAPL
AMZN
BMBL
CMG
Tags
Recent Press Releases
CRSP
ONT
From
Motley Fool
FDA Recommends At Least 15 years Of Follow-Up For Genome Editing Product Trials
March 15, 2022
Tickers
BLUE
NTLA
Tags
General
News
BLUE
From
Benzinga
Here's How Much $100 Invested In Intellia Therapeutics 5 Years Ago Would Be Worth Today
March 15, 2022
Tickers
NTLA
Tags
Market News
Earnings
News
From
Benzinga
Intellia's CRISPR-Engineered Cell Therapy Receives FDA Orphan Drug Tag For Bone Marrow Cancer
March 10, 2022
Tickers
NTLA
Tags
Health Care
General
News
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2022
March 07, 2022
Tickers
AAL
AU
AUGX
AZUL
Tags
Benzinga
AU
LYG
From
Benzinga
63 Biggest Movers From Yesterday
March 04, 2022
Tickers
AEO
ANGH
APCX
ATNX
Tags
CTIC
LEDS
BDR
From
Benzinga
Is Intellia a Good Gene-Editing Stock to Buy Now?
March 03, 2022
Tickers
NTLA
REGN
Tags
NTLA
Market News
Recent Press Releases
From
Motley Fool
Can Biotech Stocks Provide Crypto-Like Growth for Your Portfolio?
March 03, 2022
Tickers
BNTX
BTC
CRSP
ETH
Tags
NTLA
Market News
ETH
From
Motley Fool
80 Biggest Movers From Yesterday
March 02, 2022
Tickers
ALBO
AMBA
AMLX
ANPC
Tags
NFE
Pre/Market Outlook
NBSE
From
Benzinga
44 Stocks Moving In Tuesday's Mid-Day Session
March 01, 2022
Tickers
AMBA
AREB
ATRA
ATXI
Tags
News
UK
IGT
From
Benzinga
Analyst Ratings For Intellia Therapeutics
March 01, 2022
Tickers
NTLA
Tags
Analyst Ratings
Market News
NTLA
From
Benzinga
The Daily Biotech Pulse: Legend Biotech, CTI Biopharma Receive FDA Approvals, AbbVie Announces Delay In Skyrizi Review, Editas Gains On CRISPR Patent Resolution
March 01, 2022
Tickers
ABBV
AMRN
AMRS
AVID
Tags
LEGN
General
Earnings
From
Benzinga
Intellia Shares Updated Data On Gene Editing Durability In Rare Disease
March 01, 2022
Tickers
NTLA
REGN
Tags
General
News
Briefs
From
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
February 28, 2022
Tickers
ATXI
BIMI
CKPT
FGEN
Tags
ATXI
Movers
CKPT
From
Benzinga
This new competitor to the ARK Innovation ETF focuses on disruptive companies but aims to reduce volatility
February 28, 2022
Tickers
AMZN
ARKK
BLL
COIN
Tags
GOOG
CRM
NOW
From
MarketWatch
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.